Abstract
Hyperthermia is a state of thermoregulatory failure resulting from excessive heat production with a normal rate of heat loss (e.g. malignant hyperthermia) or inability to dissipate heat at a sufficient rate (e.g. heat stroke). Dehydration is the most common cause of mild hyperthermia. Hyperthermia may coexist with fever: e.g. dehydration may occur on top of fever due to infection.
In contrast to fever, hyperthermia is not mediated by pyrogen or interleukin-1 (IL-1), and the body temperature is higher than the hypothalamic set point, which is usually normal. Because hyperthermia is not regulated centrally, a temperature in excess of 42 °C is common, and the presence of such degree makes hyperthermia a likely diagnosis. This very high degree of temperature rarely occurs, if ever, with fever alone, even with the most severe infections.
Hyperthermia caused by increased heat production includes physiologically exercise-induced hyperthermia, pathologically malignant hyperthermia, neuroleptic malignant syndrome, serotonin syndrome, drug-induced hyperthermia, and endocrine hyperthermia. Hyperthermia caused by decreased heat loss includes neonatal hyperthermia, heat stroke, haemorrhagic shock and encephalopathy, sudden infant death syndrome (SIDS) and drug-induced hyperthermia. Heat stroke is due to failure of the heat-regulating mechanisms of the hypothalamus subsequent to inhibition of sweating. It is defined as a core temperature greater than 40.6 °C, accompanied by hot, dry skin and CNS abnormalities such as convulsion, delirium and coma. The two principal causes of heat stroke are high ambient temperature and water deprivation. If the temperature rises above 40.2 °C, cell deaths occur, and the condition is associated with high mortality of around 80%.
The chapter also describes “unclassified hyperthermia” such as factitious fever, induced illness and induced illness by proxy.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Clinical Effects of Hyperthermia
Bynum GD, Pandolf KB, Schuette WH, et al. Induced hyperthermia in sedated humans and the concept of critical thermal maximum. Am J Phys. 1978;235:R228–36.
Exercise-Induced Hyperthermia
Bar-Or O. Climate and the exercising child-review. Int J Sports Med. 1980;1:53–65.
Committee on sports medicine. Climatic heat stress and the exercising child. Pediatrics. 1982;69:808–9.
Malignant Hyperthermia (MH)
Girard T, Joehr M, Schaefer C, et al. Perinatal diagnosis of malignant hyperthermia susceptibility. Anesthesiology. 2006;104:1353–6.
Neuroleptic Malignant Syndrome (NMS)
Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am. 1993;77:185–202.
Nierenberg D, Disch M, Manheimer E, et al. Facilitating prompt diagnosis and treatment of the neuroleptic malignant syndrome. Clin Pharmacol Ther. 1991;50:580–6.
Oruch R, Pryme IF, Engelsen BA, et al. Neuroleptic malignant syndrome: an easily overlooked neurologic emergency. Neuropsychiatr Dis Treat. 2017;13:161–75.
Serotonin Syndrome
Halloran L, Bernard DW. Management of drug-induced hyperthermia. Curr Opin Pedaitr. 2004;16:211–5.
Endocrine Hyperthermia
Simon HB, Daniels GH. Hormonal hyperthermia, endocrinological causes of fever. Am J Med. 1979;66:257–63.
Kilbane BJ, Mehta S, Backeljauw PF, et al. Approach to management of malignant hyperthermia-like syndrome in pediatric diabetes mellitus. Pediatr Crit Care Med. 2006;7:169–73.
Goodman EL, Knochel JP. Endocrine hyperthermia. Heat stroke and other forms of hyperthermia. In: Mackowiak P, editor. Fever: basic mechanisms and management. New York: Raven Press; 1991. p. 281.
Neonatal Hyperthermia
Ws C. The early detection of pyrexia in the newborn. Arch Dis Child. 1963;38:29–39.
Heat Stroke
Knochel JP. Environmental heat loss. Arch Intern Med. 1974;133:841–65.
McLaren C, Null J, Quinn J. Heat stroke from enclosed vehicles: moderate ambient temperatures cause significant temperature rise in enclosed vehicles. Pediatrics. 2005;116:217.
Ferrara P, Vena F, Caporale O, et al. Children left unattended in parked vehicles: a focus on recent Italian cases and a review of literature. Ital J Pediatr. 2013;39:71.
Van Gestel JPJ, L’Hoir MP, ten-Berge M, et al. Risk of ancient parties in modern times. Pediatrics. 2002;110(6):1–3.
Hemorrhagic Shock and Encephalopathy (HSE)
Levin M, Kay JDS, Gould JD, et al. Hemorrhagic shock and encephalopathy. A new syndrome with high mortality in young children. Lancet. 1983;2:64–7.
Levin M, Pincott JR, Hjelm M, et al. Haemorrhagic shock and encephalopathy: clinical, pathologic, and biochemical features. J Pediatr. 1989;114:194–203.
Drug-Induced Hyperthermia
Grosso S, Franzoni E, Iannetti P, et al. Efficacy and safety of topiramate in refractory epilepsy. J Child Neurol. 2005;20:893–7.
Unclassified Hyperthermia
Sudden Death Infant Syndrome (SIDS)
American Academy of Pediatrics. The changing concept of SIDS: diagnosis, coding shifts, controversies regarding the sleeping environment. New variables to consider in reducing risk. Pediatrics. 2005;116:1245–55.
Blair PS, Sidebotham P, Berry PJ, et al. Major epidemiological changes in SIDS: a 20-year population-based study in the UK. Lancet. 2006;367:314–9.
Stanton AN. Overheating and cot death. Lancet. 1984;3:1199–201.
Factitious Hyperthermia
Rumans LW, Vosti KL. Factitious and fraudulent fever. Am J Med. 1978;65:745–55.
Edwards MS, Butler KM. Hyperthermia of trickery in an adolescent. Pediatr Infect Dis J. 1987;6:411–4.
Induced Illness
Asher R. Munchausen’s syndrome. Lancet 1951; 1: 339–41.
Sneed RC, Bell RF. The dauphin of Munchausen: factitious passage of renal stones in a child. Pediatrics. 1976;58:127–30.
Libow JA. Child and adolescent illness falsification. Pediatrics. 2000;105:336–42.
Induced Illness by Proxy
Meadow R. Munchausen syndrome by proxy: the hinterland of child abuse. Lancet. 1977;2:343–5.
Meadow R. Munchausen syndrome by proxy. Arch Dis Child. 1982;57:92–8.
Bools CN, Neale BA, Meadow SR. Co-morbidity associated with fabricated illness (Munchausen syndrome by proxy). Arch Dis Child. 1992;67:77–9.
Therapeutic Effects of Hyperthermia
Yerurshalmi A, Lwoff A. Traitement du coryza infectieux et des rhinitis persistantes allergiques par la thermotherapy. Camp Rendus Seances Acad Sci (Paris). 1980;291(Ser D):957–9.
Pennypacker C, Perelson AS, Nys N. Localized or systemic in vivo heat inactivation of HIV: a mathematical analysis. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:321–9.
Ismail ZRS, Zhavrid EA, Potapnev MP. Whole body hyperthermia in adjuvant therapy of children with renal cell carcinoma. Pediatr Blood Cancer. 2005;44:679–81.
Shields CL, Meadows AT, Leahey AM, et al. Continuing challenges in the management of retinoblastoma with chemotherapy. Retina. 2004;24:849–62.
Seifert G, Budach V, Keilholz U, et al. Regional hyperthermia combined with chemotherapy in paediatric, adolescents, and young adult patients: current and future perspectives. Radiat Oncol. 2016;11:65.
Man J, Shoemake J, Ma T, et al. Hyperthermia sensitizes glioma stem-like cells to radiation by inhibiting AKT signaling. Cancer Res. 2015;75(8):1760–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
El-Radhi, A.S. (2018). Hyperthermia. In: El-Radhi, A. (eds) Clinical Manual of Fever in Children. Springer, Cham. https://doi.org/10.1007/978-3-319-92336-9_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-92336-9_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-92335-2
Online ISBN: 978-3-319-92336-9
eBook Packages: MedicineMedicine (R0)